ODE IV Deputy Director Cox Will Emphasize Antimicrobial Drug Development
Executive Summary
FDA Division of Special Pathogen & Immunologic Drug Products Medical Team Leader Edward Cox, MD, plans to continue to focus on development of antimicrobial drugs that target resistant pathogens following his appointment as FDA's Office of Drug Evaluation IV deputy director